p-Toluenesulfonic acid → HCID 46206559, compound
Reaction equation
[C:1]([C:4]1[N:5]=[C:6]([C:28]2[CH:36]=[C:35]3[C:31]([CH:32]=[CH:33][NH:34]3)=[CH:30][CH:29]=2)[O:7][C:8]=1[C:9]1[CH:14]=[CH:13][C:12]([N:15]2[CH2:20][CH2:19][N:18](C(OC(C)(C)C)=O)[CH2:17][CH2:16]2)=[CH:11][CH:10]=1)(=[O:3])[NH2:2].CC1C=CC(S(O)(=O)=O)=CC=1>CO>[NH:34]1[C:35]2[C:31](=[CH:30][CH:29]=[C:28]([C:6]3[O:7][C:8]([C:9]4[CH:10]=[CH:11][C:12]([N:15]5[CH2:20][CH2:19][NH:18][CH2:17][CH2:16]5)=[CH:13][CH:14]=4)=[C:4]([C:1]([NH2:2])=[O:3])[N:5]=3)[CH:36]=2)[CH:32]=[CH:33]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of tert-butyl 4-(4-(4-carbamoyl-2-(1H-indol-6-yl)oxazol-5-yl)phenyl)piperazine-1-carboxylate (0.018 g, 0.04 mmol) in MeOH was loaded onto a MP-TsOH cartridge (500 mg). The cartridge was washed with MeOH and allowed to stand for 2 hours. The cartridge was then washed with 2M ammonia in MeOH and the solvent removed in vacuo. The residue was purified by preparative HPLC to afford 2-(1H-indol-6-yl)-5-(4-(piperazin-1-yl)phenyl)oxazole-4-carboxamide (0.006 g, 0.02 mmol, 50%). 1H NMR (DMSO) δ 2.85 (4H, t), 3.20 (4H, t), 6.55 (1H, m), 7.04 (2H, d), 7.55 (1H, br. s), 7.56 (1H, m), 7.68 (1H, br. s), 7.71 (1H, d), 7.77 (1H, dd), 8.15 (1H, s), 8.26 (2H, d), 11.48 (1H, br. s). LCMS (2) Rt: 2.32 min; m/z (ES+) 388.
Workup
- washThe cartridge was washed with MeOH
- washThe cartridge was then washed with 2M ammonia in MeOH
- customthe solvent removed in vacuo
- customThe residue was purified by preparative HPLC
Sources & evidence
- ORD record
- ord-862091a246774be1a18e8cd190e55aa2
- Source dataset
- uspto-grants-2013_02
- Patent number
- US08378095B2
Reaction notes
Loading…